| Item Type | Name |
|
Concept
|
Kruppel-Like Transcription Factors
|
|
Concept
|
Alprostadil
|
|
Concept
|
Body Mass Index
|
|
Concept
|
Famous Persons
|
|
Concept
|
Vascular Endothelial Growth Factor A
|
|
Concept
|
Insulin
|
|
Concept
|
Financing, Government
|
|
Concept
|
Extracellular Matrix
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
Precision Medicine
|
|
Concept
|
DNA Methylation
|
|
Concept
|
Prostaglandins G
|
|
Concept
|
Esophageal Neoplasms
|
|
Concept
|
Transforming Growth Factor beta
|
|
Concept
|
Dextran Sulfate
|
|
Concept
|
Arachidonic Acid
|
|
Concept
|
NF-kappa B
|
|
Concept
|
Calcimycin
|
|
Concept
|
Adrenergic beta-Agonists
|
|
Concept
|
Colonoscopy
|
|
Concept
|
Flow Cytometry
|
|
Concept
|
Phenylbutyrates
|
|
Concept
|
Tumor Suppressor Protein p53
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Genes, Tumor Suppressor
|
|
Concept
|
Recurrence
|
|
Concept
|
Morbidity
|
|
Concept
|
Cell Nucleus
|
|
Concept
|
S Phase
|
|
Concept
|
Cell Division
|
|
Concept
|
Blood Vessels
|
|
Concept
|
Keratin-20
|
|
Concept
|
Phospholipase D
|
|
Concept
|
Gene Expression
|
|
Concept
|
COS Cells
|
|
Concept
|
Epoprostenol
|
|
Concept
|
Ileum
|
|
Concept
|
Dietary Fats
|
|
Concept
|
RNA Interference
|
|
Concept
|
Isoproterenol
|
|
Concept
|
DNA, Complementary
|
|
Concept
|
Fluorescent Antibody Technique
|
|
Concept
|
Eicosanoids
|
|
Concept
|
Disease Progression
|
|
Concept
|
CD8-Positive T-Lymphocytes
|
|
Concept
|
Pharmacogenetics
|
|
Concept
|
Nuclear Receptor Subfamily 4, Group A, Member 2
|
|
Concept
|
Endothelium, Vascular
|
|
Concept
|
Adenomatous Polyps
|
|
Concept
|
Intermediate Filament Proteins
|
|
Concept
|
Cell Adhesion
|
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
|
Concept
|
History, 21st Century
|
|
Concept
|
Genes, Dominant
|
|
Concept
|
PPAR-beta
|
|
Concept
|
Cyclins
|
|
Concept
|
Food
|
|
Concept
|
Collagen Type I
|
|
Concept
|
Chromones
|
|
Concept
|
Progesterone
|
|
Concept
|
Cyclin-Dependent Kinase Inhibitor p21
|
|
Concept
|
Stearic Acids
|
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Protein Biosynthesis
|
|
Concept
|
Amino Acid Sequence
|
|
Concept
|
Patient Education as Topic
|
|
Concept
|
Anticarcinogenic Agents
|
|
Concept
|
Eicosapentaenoic Acid
|
|
Concept
|
Antineoplastic Agents
|
|
Concept
|
Cytochrome P-450 Enzyme System
|
|
Concept
|
Lipid Peroxidation
|
|
Concept
|
Culture Media
|
|
Concept
|
Cytidine Deaminase
|
|
Concept
|
Angiopoietins
|
|
Concept
|
Phospholipases A
|
|
Concept
|
Health Promotion
|
|
Concept
|
Precipitin Tests
|
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
STAT3 Transcription Factor
|
|
Concept
|
Blotting, Western
|
|
Concept
|
Butyrates
|
|
Concept
|
Leukotriene A4
|
|
Concept
|
Hydroxyeicosatetraenoic Acids
|
|
Concept
|
Adenomatous Polyposis Coli Protein
|
|
Concept
|
Research Support as Topic
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Prostate-Specific Antigen
|
|
Concept
|
Lymphokines
|
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
|
Concept
|
Energy Metabolism
|
|
Concept
|
Enzyme Induction
|
|
Concept
|
Densitometry
|
|
Concept
|
Ovum Transport
|
|
Concept
|
Clinical Trials as Topic
|
|
Concept
|
Cell Line, Transformed
|
|
Concept
|
DNA Primers
|
|
Concept
|
Vascular Endothelial Growth Factors
|
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
|
Concept
|
Adenocarcinoma
|
|
Concept
|
Transcription, Genetic
|
|
Concept
|
Receptors, Prostaglandin E
|
|
Concept
|
Histone Deacetylases
|
|
Concept
|
Colitis
|
|
Concept
|
Tumor Necrosis Factor-alpha
|
|
Concept
|
Genes, APC
|
|
Concept
|
Dinoprostone
|
|
Concept
|
Repressor Proteins
|
|
Concept
|
Lipid Peroxides
|
|
Concept
|
Mammary Glands, Human
|
|
Concept
|
Matrix Metalloproteinase 9
|
|
Concept
|
Estrogens
|
|
Concept
|
Matrix Metalloproteinase 2
|
|
Concept
|
Genes, ras
|
|
Concept
|
Bone Morphogenetic Proteins
|
|
Concept
|
Intestinal Neoplasms
|
|
Concept
|
Retrospective Studies
|
|
Concept
|
Fertilization
|
|
Concept
|
Leukotrienes
|
|
Concept
|
HT29 Cells
|
|
Concept
|
Cells, Cultured
|
|
Concept
|
Caco-2 Cells
|
|
Concept
|
Academic Medical Centers
|
|
Concept
|
Cell Hypoxia
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
T-Lymphocytes
|
|
Concept
|
Oxygen
|
|
Concept
|
Early Growth Response Protein 1
|
|
Concept
|
Liver Neoplasms, Experimental
|
|
Concept
|
Microtubule-Associated Proteins
|
|
Concept
|
Transforming Growth Factor beta1
|
|
Concept
|
Postmenopause
|
|
Concept
|
MAP Kinase Kinase 1
|
|
Concept
|
Monocytes
|
|
Concept
|
Arachidonate 5-Lipoxygenase
|
|
Concept
|
Xenograft Model Antitumor Assays
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
PPAR delta
|
|
Concept
|
Transgenes
|
|
Concept
|
Epoxide Hydrolases
|
|
Concept
|
Homeodomain Proteins
|
|
Concept
|
beta Catenin
|
|
Concept
|
Arrestins
|
|
Concept
|
Jejunum
|
|
Concept
|
History, 20th Century
|
|
Concept
|
Linoleic Acids
|
|
Concept
|
Peroxisome Proliferator-Activated Receptors
|
|
Concept
|
Adaptor Proteins, Signal Transducing
|
|
Concept
|
Receptors, Prostaglandin
|
|
Concept
|
Genes, Reporter
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Cytotoxicity, Immunologic
|
|
Concept
|
DNA Damage
|
|
Concept
|
Health Care Costs
|
|
Concept
|
Cell Membrane
|
|
Concept
|
Fibrinolysin
|
|
Concept
|
Norepinephrine
|
|
Concept
|
ras Proteins
|
|
Concept
|
Transforming Growth Factor alpha
|
|
Concept
|
Metabolomics
|
|
Concept
|
Antioxidants
|
|
Concept
|
Inhibitor of Apoptosis Proteins
|
|
Concept
|
Fatty Acids
|
|
Concept
|
Oxidation-Reduction
|
|
Concept
|
Carcinoma
|
|
Concept
|
Aromatase
|
|
Concept
|
Mass Screening
|
|
Concept
|
Endothelial Growth Factors
|
|
Concept
|
Proto-Oncogene Proteins c-jun
|
|
Concept
|
Chemokines, CXC
|
|
Concept
|
Epidermal Growth Factor
|
|
Concept
|
Atmospheric Pressure
|
|
Concept
|
Nitrites
|
|
Concept
|
Extracellular Signal-Regulated MAP Kinases
|
|
Concept
|
Health Status Disparities
|
|
Concept
|
Colonic Polyps
|
|
Concept
|
Collagen
|
|
Concept
|
Proto-Oncogene Proteins p21(ras)
|
|
Concept
|
PPAR gamma
|
|
Concept
|
I-kappa B Proteins
|
|
Concept
|
Adenomatous Polyposis Coli
|
|
Concept
|
In Situ Hybridization
|
|
Concept
|
Randomized Controlled Trials as Topic
|
|
Concept
|
Inflammatory Bowel Diseases
|
|
Concept
|
Urokinase-Type Plasminogen Activator
|
|
Concept
|
Trophoblasts
|
|
Concept
|
Cell Growth Processes
|
|
Concept
|
Cell Line
|
|
Concept
|
Isoprostanes
|
|
Concept
|
Carbonyl Cyanide m-Chlorophenyl Hydrazone
|
|
Concept
|
Proto-Oncogene Proteins c-fos
|
|
Concept
|
STAT1 Transcription Factor
|
|
Concept
|
F2-Isoprostanes
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Phospholipases A2
|
|
Concept
|
Microinjections
|
|
Concept
|
DNA Repair
|
|
Concept
|
Chemokine CXCL1
|
|
Concept
|
Histone Deacetylase 2
|
|
Concept
|
Colon
|
|
Concept
|
Ibuprofen
|
|
Concept
|
Arachidonic Acids
|
|
Concept
|
Cytosol
|
|
Concept
|
Risk Factors
|
|
Concept
|
Chemokines
|
|
Concept
|
Promoter Regions, Genetic
|
|
Concept
|
Gene Silencing
|
|
Concept
|
Nuclear Receptor Subfamily 4, Group A, Member 1
|
|
Concept
|
Base Sequence
|
|
Concept
|
Follow-Up Studies
|
|
Concept
|
HCT116 Cells
|
|
Concept
|
Zebrafish
|
|
Concept
|
Killer Cells, Natural
|
|
Concept
|
Carcinoma, Small Cell
|
|
Concept
|
Immunohistochemistry
|
|
Concept
|
Colonic Neoplasms
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Molecular Sequence Data
|
|
Concept
|
Hypoxia-Inducible Factor 1, alpha Subunit
|
|
Concept
|
Antibiotics, Antineoplastic
|
|
Concept
|
Prostaglandins
|
|
Concept
|
Gastrointestinal Neoplasms
|
|
Academic Article
|
Prostaglandin Gbetagamma signaling stimulates gastrulation movements by limiting cell adhesion through Snai1a stabilization.
|
|
Academic Article
|
Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation.
|
|
Academic Article
|
Cyclooxygenase-1 signaling is required for vascular tube formation during development.
|
|
Academic Article
|
Kr?ppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1.
|
|
Academic Article
|
The Role of Prostaglandin E(2) in Tumor-Associated Immunosuppression.
|
|
Academic Article
|
AACR Cancer Progress Report 2015.
|
|
Academic Article
|
Immunosuppression associated with chronic inflammation in the tumor microenvironment.
|
|
Academic Article
|
The Jeremiah Metzger Lecture: Inflammation, Immune Modulators, and Chronic Disease.
|
|
Academic Article
|
PPARd and PGE2 signaling pathways communicate and connect inflammation to colorectal cancer.
|
|
Academic Article
|
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
|
|
Academic Article
|
Role of inflammation and inflammatory mediators in colorectal cancer.
|
|
Academic Article
|
CG100649, a novel COX-2 inhibitor, inhibits colorectal adenoma and carcinoma growth in mouse models.
|
|
Academic Article
|
Myeloid-derived suppressor cells link inflammation to cancer.
|
|
Academic Article
|
Peroxisome proliferator-activated receptor d promotes colonic inflammation and tumor growth.
|
|
Academic Article
|
An inflammatory mediator, prostaglandin E2, in colorectal cancer.
|
|
Academic Article
|
CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis.
|
|
Academic Article
|
HIG2 promotes colorectal cancer progression via hypoxia-dependent and independent pathways.
|
|
Academic Article
|
Changes in cancer cell metabolism revealed by direct sample analysis with MALDI mass spectrometry.
|
|
Academic Article
|
Urinary PGE-M: a promising cancer biomarker.
|
|
Academic Article
|
Prostaglandin E2 regulates pancreatic stellate cell activity via the EP4 receptor.
|
|
Academic Article
|
PPAR? agonists target aromatase via both PGE2 and BRCA1.
|
|
Academic Article
|
The role of anti-inflammatory drugs in colorectal cancer.
|
|
Academic Article
|
AACR Cancer Progress Report 2012.
|
|
Academic Article
|
Biomarkers, bundled payments, and colorectal cancer care.
|
|
Academic Article
|
Metronomic topotecan for colorectal cancer: a promising new option.
|
|
Academic Article
|
Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients.
|
|
Academic Article
|
The role of the PGE2-aromatase pathway in obesity-associated breast inflammation.
|
|
Academic Article
|
Prostaglandins in cancer cell adhesion, migration, and invasion.
|
|
Academic Article
|
Associations between obesity and cancer: the role of fatty acid synthase.
|
|
Academic Article
|
Overview of the AACR Clinical and Translational Cancer Research Think Tank meeting.
|
|
Academic Article
|
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation.
|
|
Academic Article
|
Epoxyeicosatrienoic acids: a double-edged sword in cardiovascular diseases and cancer.
|
|
Academic Article
|
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America.
|
|
Academic Article
|
APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis.
|
|
Academic Article
|
ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression.
|
|
Academic Article
|
Nuclear orphan receptor NR4A2 modulates fatty acid oxidation pathways in colorectal cancer.
|
|
Academic Article
|
The tumor microenvironment in colorectal carcinogenesis.
|
|
Academic Article
|
The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer.
|
|
Academic Article
|
Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.
|
|
Academic Article
|
Tailoring treatment in translational cancer research: An Interview with Raymond N. DuBois, MD, PhD. Interviewed by Elaine Musgrave.
|
|
Academic Article
|
Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells.
|
|
Academic Article
|
Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.
|
|
Academic Article
|
Eicosanoids and cancer.
|
|
Academic Article
|
HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells.
|
|
Academic Article
|
The role of chemokines in intestinal inflammation and cancer.
|
|
Academic Article
|
New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.
|
|
Academic Article
|
Regulation of prostaglandin transporters in colorectal neoplasia.
|
|
Academic Article
|
Repression of 15-hydroxyprostaglandin dehydrogenase involves histone deacetylase 2 and snail in colorectal cancer.
|
|
Academic Article
|
Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.
|
|
Academic Article
|
Peroxisome proliferator-activated receptor beta/delta expression and activation in lung cancer.
|
|
Academic Article
|
Peroxisome proliferator-activated receptors and progression of colorectal cancer.
|
|
Academic Article
|
Pro-inflammatory prostaglandins and progression of colorectal cancer.
|
|
Academic Article
|
Stage-specific integration of maternal and embryonic peroxisome proliferator-activated receptor delta signaling is critical to pregnancy success.
|
|
Academic Article
|
Measurement of eicosanoids in cancer tissues.
|
|
Academic Article
|
Cyclooxygenase-2-mediated metabolism of arachidonic acid to 15-oxo-eicosatetraenoic acid by rat intestinal epithelial cells.
|
|
Academic Article
|
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.
|
|
Academic Article
|
Inhibition of epidermal growth factor receptor signaling elevates 15-hydroxyprostaglandin dehydrogenase in non-small-cell lung cancer.
|
|
Academic Article
|
Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer.
|
|
Academic Article
|
Priorities in colorectal cancer research: recommendations from the Gastrointestinal Scientific Leadership Council of the Coalition of Cancer Cooperative Groups.
|
|
Academic Article
|
MEK activation suppresses CPT11-induced apoptosis in rat intestinal epithelial cells through a COX-2-dependent mechanism.
|
|
Academic Article
|
Inflammatory mediators and nuclear receptor signaling in colorectal cancer.
|
|
Academic Article
|
Crosstalk between peroxisome proliferator-activated receptor delta and VEGF stimulates cancer progression.
|
|
Academic Article
|
Gene expression profiling following constitutive activation of MEK1 and transformation of rat intestinal epithelial cells.
|
|
Academic Article
|
NSAIDs and cancer prevention: targets downstream of COX-2.
|
|
Academic Article
|
Emerging roles of beta-arrestins.
|
|
Academic Article
|
Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.
|
|
Academic Article
|
Cyclooxygenase-2 selective inhibitors and prostate cancer: what is the clinical benefit?
|
|
Academic Article
|
Ras up-regulation of cyclooxygenase-2.
|
|
Academic Article
|
Cancer prevention: strategy for the future.
|
|
Academic Article
|
NSAIDs and prostate cancer risk.
|
|
Academic Article
|
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.
|
|
Academic Article
|
Bmp signaling is required for intestinal growth and morphogenesis.
|
|
Academic Article
|
Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.
|
|
Academic Article
|
Connecting COX-2 and Wnt in cancer.
|
|
Academic Article
|
The COX-2 story: is any drug completely "safe?".
|
|
Academic Article
|
Fishing for prostanoids: deciphering the developmental functions of cyclooxygenase-derived prostaglandins.
|
|
Academic Article
|
Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer.
|
|
Academic Article
|
Mechanisms of disease: Inflammatory mediators and cancer prevention.
|
|
Academic Article
|
The emerging role and potential of COX-2 inhibitors.
|
|
Academic Article
|
Mechanisms for the prevention of gastrointestinal cancer: the role of prostaglandin E2.
|
|
Academic Article
|
Inflammation in the genesis and perpetuation of cancer: summary and recommendations from a national cancer institute-sponsored meeting.
|
|
Academic Article
|
Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages.
|
|
Academic Article
|
Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2.
|
|
Academic Article
|
Cyclooxygenase-2-mediated DNA damage.
|
|
Academic Article
|
The role of prostaglandins and other eicosanoids in the gastrointestinal tract.
|
|
Academic Article
|
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer.
|
|
Academic Article
|
COX-2: a molecular target for colorectal cancer prevention.
|
|
Academic Article
|
Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade.
|
|
Academic Article
|
Outcome of upper gastro-intestinal bleeding and use of ibuprofen versus paracetamol.
|
|
Academic Article
|
Requirement of phospholipase D1 activity in H-RasV12-induced transformation.
|
|
Academic Article
|
Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
|
|
Academic Article
|
15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer.
|
|
Academic Article
|
WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth.
|
|
Academic Article
|
Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor.
|
|
Academic Article
|
Disease prevention: the future is here.
|
|
Academic Article
|
Prostaglandin E2 regulates the complement inhibitor CD55/decay-accelerating factor in colorectal cancer.
|
|
Academic Article
|
Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.
|
|
Academic Article
|
Aberrant cannabinoid signaling impairs oviductal transport of embryos.
|
|
Academic Article
|
Effects of transforming growth factor-alpha (TGF-alpha) in vitro and in vivo on reovirus replication.
|
|
Academic Article
|
Cyclooxygenase-2 and gastrointestinal cancer.
|
|
Academic Article
|
In vivo immediate early gene expression induced in intestinal and colonic mucosa by feeding.
|
|
Academic Article
|
COX-2: a target for colon cancer prevention.
|
|
Academic Article
|
Cyclooxygenase-2: a therapeutic target.
|
|
Academic Article
|
Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
|
|
Academic Article
|
Peroxisome proliferator-activated receptors modulate K-Ras-mediated transformation of intestinal epithelial cells.
|
|
Academic Article
|
The evolution of modern academic medicine continues.
|
|
Academic Article
|
Controversy: PPARgamma as a target for treatment of colorectal cancer.
|
|
Academic Article
|
Controversies in COX-2 selective inhibition.
|
|
Academic Article
|
New agents for cancer prevention.
|
|
Academic Article
|
Peroxisome proliferator-activated receptor gamma and transforming growth factor-beta pathways inhibit intestinal epithelial cell growth by regulating levels of TSC-22.
|
|
Academic Article
|
New avenues for the prevention of colorectal cancer: targeting cyclo-oxygenase-2 activity.
|
|
Academic Article
|
Expression of hypoxia-inducible factors in the peri-implantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy.
|
|
Academic Article
|
Peroxisome proliferator-activated receptor gamma-mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms.
|
|
Academic Article
|
Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer.
|
|
Academic Article
|
Evaluation of the whole prostaglandin biosynthetic pathway in lung cancer.
|
|
Academic Article
|
Intestinal transformation results in transforming growth factor-beta-dependent alteration in tumor cell-cell matrix interactions.
|
|
Academic Article
|
Cyclooxygenase-2 and colorectal cancer.
|
|
Academic Article
|
Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.
|
|
Academic Article
|
Leukotriene A4 signaling, inflammation, and cancer.
|
|
Academic Article
|
Will an aspirin a day keep the endoscope away?
|
|
Academic Article
|
The physician-scientist in gastroenterology.
|
|
Academic Article
|
Targeted lipidomics using electron capture atmospheric pressure chemical ionization mass spectrometry.
|
|
Academic Article
|
The cyclooxygenase-2 pathway as a target for treatment or prevention of cancer.
|
|
Academic Article
|
Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging.
|
|
Academic Article
|
Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch.
|
|
Academic Article
|
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-delta accelerates intestinal adenoma growth.
|
|
Academic Article
|
Cyclooxygenase-2: a potential target in breast cancer.
|
|
Academic Article
|
Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture.
|
|
Academic Article
|
Aspirin and breast cancer prevention: the estrogen connection.
|
|
Academic Article
|
15-LOX-1 inhibits p21 (Cip/WAF 1) expression by enhancing MEK-ERK 1/2 signaling in colon carcinoma cells.
|
|
Academic Article
|
Novel agents in the treatment of lung cancer: conference summary statement.
|
|
Academic Article
|
Cyclooxygenase as a target in lung cancer.
|
|
Academic Article
|
COX-2 inhibition and colorectal cancer.
|
|
Academic Article
|
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.
|
|
Academic Article
|
Role of prostanoids in gastrointestinal cancer.
|
|
Academic Article
|
AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health.
|
|
Academic Article
|
Cancer Prevention: A Message from the New Editors-in-Chief.
|
|
Academic Article
|
PPARd Mediates the Effect of Dietary Fat in Promoting Colorectal Cancer Metastasis.
|
|
Academic Article
|
Prostaglandin E2 Induces miR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression.
|
|
Academic Article
|
COVID-19, Cancer Care and Prevention.
|
|
Academic Article
|
Meeting Report: Translational Advances in Cancer Prevention Agent Development Meeting.
|
|
Academic Article
|
Fibroblasts fuel intestinal tumorigenesis.
|
|
Concept
|
Diet, High-Fat
|
|
Concept
|
Receptors, Prostaglandin E, EP1 Subtype
|
|
Concept
|
Receptors, Prostaglandin E, EP4 Subtype
|
|
Concept
|
Pandemics
|
|
Concept
|
B7-H1 Antigen
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Fatty Acid Synthases
|
|
Concept
|
Celecoxib
|
|
Concept
|
Nanog Homeobox Protein
|
|
Concept
|
APOBEC-3G Deaminase
|
|
Concept
|
beta-Arrestins
|
|
Concept
|
beta-Arrestin 1
|
|
Concept
|
Zinc Finger E-box-Binding Homeobox 1
|
|
Concept
|
NF-KappaB Inhibitor alpha
|
|
Concept
|
Cancer-Associated Fibroblasts
|
|
Concept
|
HEK293 Cells
|
|
Academic Article
|
Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer.
|
|
Academic Article
|
The Urgent Need for Expanded Cancer Screening.
|
|
Academic Article
|
Cyclooxygenases and Prostaglandins in Tumor Immunology and Microenvironment of Gastrointestinal Cancer.
|
|
Academic Article
|
The First Lady Presses for Cancer Screening to Get Back On Track.
|
|
Academic Article
|
The COX-2-PGE2 Pathway Promotes Tumor Evasion in Colorectal Adenomas.
|
|
Academic Article
|
Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer.
|
|
Academic Article
|
Introducing Cancer Center Director Perspectives on Prevention.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|
|
Academic Article
|
The AACR Journals: Advancing Progress Toward the AACR's 115-Year Mission.
|